# Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

> **NCT05159427** · PHASE1 · RECRUITING · sponsor: **University of Michigan** · enrollment: 40 (estimated)

## Conditions studied

- Human Gastrointestinal Physiology Data

## Interventions

- **DRUG:** Glucotrol XL 5Mg Extended-Release Tablet
- **DRUG:** Glipizide ER 5 MG 24 HR Extended Release Oral Tablet
- **DRUG:** Rifaximin 200Mg Tab
- **DRUG:** 13C6-Glipizide

## Key facts

- **NCT ID:** NCT05159427
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-15
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05159427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05159427, "Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT05159427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*